Tech Company Financing Transactions
Norgine B.V. Funding Round
Norgine B.V., based in Amsterdam, secured $31 million in investment from .
Transaction Overview
Company Name
Announced On
3/5/2026
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Undisclosed
Investors
No investors have been recorded for this company.
Proceeds Purpose
The investment will strengthen Norgine's ability to reliably supply much-needed medicines across the UK and Europe at a time of increasing global supply chain volatility, while creating 44 new skilled jobs and reinforcing the organisation's long term manufacturing capability in the region.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Antonio Vivaldistraat 150
Amsterdam, 1083 HP
The Netherlands
Amsterdam, 1083 HP
The Netherlands
Phone
Website
Email Address
Overview
Norgine B.V. is a privately-owned, European specialty pharmaceutical company, developing and marketing pharmaceutical products in the therapeutic areas of gastroenterology, hepatology and pain management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Stein
Chief Financial Officer
Lesley Roche
Chief Medical Officer
Alastair Benbow
Chief Operating Officer
Christopher Bath
VP - Bus. Development
Paul Pay
VP - General Counsel
Sheila Hopkins
VP - Human Resources
Tara Barry
VP - Manufacturing
Philippe Caroff
Browse more venture capital transactions:
Prev: 3/5/2026: UForce venture capital transaction
Next: 3/5/2026: ANEUVO venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs